Clinical trial
Biological Therapy in Treating Patients With Bladder Cancer
NCT00003779 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003779 |
|---|---|
| Title | Biological Therapy in Treating Patients With Bladder Cancer |
| Official title | A Prospective Randomized Trial for the Comparison of Two BCG Strains (Bacille Calmette-Guerin) in the Prophylaxis of Papollary Bladder Tumors Stage Ta and T1 and Treatment of Carcinoma in Situ |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Biological |
| Interventions | Connaught, Tice |
| Enrollment | 40 |
| Start date | Nov 1, 1998 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2010 |
| First posted | Mar 15, 2004 |
| Last update posted | Jun 26, 2019 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: